• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Reliance Inc.

    4/3/25 5:00:09 PM ET
    $RS
    Metal Fabrications
    Industrials
    Get the next $RS alert in real time by email
    DEFA14A 1 tm252301d3_defa14a.htm DEFA14A

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No.      )

     

    Filed by the Registrant x

     

    Filed by a Party other than the Registrant ¨

     

    Check the appropriate box:

     

    ¨Preliminary Proxy Statement

     

    ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ¨Definitive Proxy Statement

     

    xDefinitive Additional Materials

     

    ¨Soliciting Material Pursuant to §240.14a-12

     

    Reliance, Inc.

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

    xNo fee required
      
    ¨Fee paid previously with preliminary materials
      
    ¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

     

     

     

    GRAPHIC

    Your Vote Counts! RELIANCE, INC. 16100 N. 71ST STREET, SUITE 400 SCOTTSDALE, AZ 85254 RELIANCE, INC. You invested in RELIANCE, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 21, 2025. Vote Virtually at the Meeting* May 21, 2025 10:00 a.m. PDT Virtually at: www.virtualshareholdermeeting.com/RS2025 *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V66664-P26479 Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 7, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. 2025 Annual Meeting Vote by May 20, 2025 11:59 PM ET. For shares held in a Plan, vote by May 16, 2025 11:59 PM ET.

    GRAPHIC

    THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V66665-P26479 1. Election of Directors Nominees: 1a. Lisa L. Baldwin For 1b. Karen W. Colonias For 1c. Frank J. Dellaquila For 1d. James K. Kamsickas For 1e. Karla R. Lewis For 1f. Robert A. McEvoy For 1g. David W. Seeger For 1h. Douglas W. Stotlar For 2. To consider a non-binding, advisory vote to approve the compensation of our named executive officers. For 3. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2025. For 4. To transact such other business, if any, as properly comes before the meeting or any adjournment thereof.

    Get the next $RS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RS

    DatePrice TargetRatingAnalyst
    1/8/2025Underperform → Peer Perform
    Wolfe Research
    12/2/2024$341.00Neutral
    Goldman
    7/26/2024$262.00Peer Perform → Underperform
    Wolfe Research
    4/11/2024$380.00Buy → Neutral
    Citigroup
    4/28/2023Outperform → Peer Perform
    Wolfe Research
    1/4/2023$231.00Neutral
    BofA Securities
    10/6/2022$218.00 → $201.00Buy → Neutral
    Goldman
    8/15/2022$230.00Outperform
    BMO Capital Markets
    More analyst ratings

    $RS
    SEC Filings

    See more
    • SEC Form 11-K filed by Reliance Inc.

      11-K - RELIANCE, INC. (0000861884) (Filer)

      6/17/25 4:37:13 PM ET
      $RS
      Metal Fabrications
      Industrials
    • SEC Form 11-K filed by Reliance Inc.

      11-K - RELIANCE, INC. (0000861884) (Filer)

      6/17/25 4:34:58 PM ET
      $RS
      Metal Fabrications
      Industrials
    • SEC Form 144 filed by Reliance Inc.

      144 - RELIANCE, INC. (0000861884) (Subject)

      5/30/25 5:11:50 PM ET
      $RS
      Metal Fabrications
      Industrials

    $RS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • September 24, 2024 - FDA Roundup: September 24, 2024

      For Immediate Release: September 24, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA held a ribbon-cutting ceremony to highlight the completion of the 64,000 square foot expansion and renovation of the National Forensic Chemistry Center (NFCC)  located in Cincinnati, Ohio.  The goal of this revitalization effort was to impro

      9/24/24 4:08:17 PM ET
      $RS
      Metal Fabrications
      Industrials

    $RS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mcevoy Robert Ambrose was granted 567 shares, increasing direct ownership by 3% to 22,814 units (SEC Form 4)

      4 - RELIANCE, INC. (0000861884) (Issuer)

      5/22/25 5:57:44 PM ET
      $RS
      Metal Fabrications
      Industrials
    • Director Baldwin Lisa was granted 567 shares, increasing direct ownership by 14% to 4,659 units (SEC Form 4)

      4 - RELIANCE, INC. (0000861884) (Issuer)

      5/22/25 5:57:19 PM ET
      $RS
      Metal Fabrications
      Industrials
    • Director Colonias Karen Winifred was granted 567 shares (SEC Form 4)

      4 - RELIANCE, INC. (0000861884) (Issuer)

      5/22/25 5:56:38 PM ET
      $RS
      Metal Fabrications
      Industrials